Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Announces Launch of New Website

3 Nov 2021 07:00

RNS Number : 1347R
Agronomics Limited
03 November 2021
 

3 November 2021

 

Agronomics Limited

("Agronomics" or the "Company")

Announces Launch of New Website

 

Agronomics, the leading listed company focused on the field of cellular agriculture, is pleased to announce the launch of its new website, found at www.agronomics.im.

This new website aligns with Agronomics focus on identifying cellular agriculture opportunities, inclusive of cultivated meat, biomass fermentation and precision fermentation. The Company to date has participated in early-stage funding rounds of BlueNalu, Meatable, VitroLabs, Solar Foods, Formo, Mosa Meat, LIVEKINDLY, Tropic Biosciences, California Cultured, SuperMeat, CellX, GALY, Bond Pet Foods, Shiok Meats, New Age Meats and Rebellyous Foods. All of which can be found under portfolio highlights on the new website.

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 16 companies at the Seed to Series B stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

About Cellular Agriculture

Over the coming decades, the source of the world's food supply traditionally derived from animals is going to change dramatically. We have already witnessed the first wave of this shift with consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change, which is being facilitated by advances in cellular agriculture - the production of proteins and materials directly from cells and single-celled organisms.

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital.

Scientists believe that if we maintain current animal protein consumption patterns and continue using animals to produce meat and other proteins from animals, that we cannot meet the Paris Agreement's goals of limiting warming to 1.5.

Funding in the field of cellular agriculture is accelerating, however still less than US$ 1 billion has been invested worldwide since the industry's inception in 2016. The Good Food Institute estimates Additional financings are anticipated as the capital requirements of these companies grows to build out and scale up manufacturing facilities. Currently it is estimated that there are 60 companies globally within the sector.

For further information please contact:

 

Agronomics

Limited

Beaumont

Cornish Limited

Cenkos

Securities Plc

Peterhouse Capital

Limited

TB Cardew

The Company

Nomad

Joint Broker

Joint Broker

 

Public Relations

Richard Reed

Denham Eke

Roland Cornish

James Biddle

Giles Balleny

Michael Johnson

Lucy Williams

Charles Goodfellow

Ed Orlebar

Joe McGregor

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 397 8900

+44 (0) 207 469 0936

+44 (0) 20 7930 0777

+44 (0) 7738 724 630

agronomics@tbcardew.com

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABTBBTMTMMTLB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.